Results 201 to 210 of about 13,099 (221)

Differential expression of miR-17∼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia

Leukemia, 2013
K Battmer, Simon Bomken, Oliver G Ottmann   +2 more
exaly  

Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features

Frontiers in Oncology, 2020
Satoshi Nishiwaki, Masafumi Itô, Yusuke Okuno   +2 more
exaly  

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Nature Medicine, 1996
Brian J Druker, Elisabeth Buchdunger, G M Segal   +2 more
exaly  

Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia

Cancer Letters, 1998
Shinsuke Harada, Kazuya Tsuboi, Shogo Banno   +2 more
exaly  

Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and/or bcr-abl positive in adult

International Journal of Hematology, 2011
Yingchang Mi, Lugui Qiu, Jianxiang Wang   +2 more
exaly  

ABL-BCR expression in BCR-ABL-positive human leukemia cell lines

Leukemia Research, 1999
Cord C Uphoff, Yoshinobu Matsuo, C C Uphoff   +2 more
exaly  

BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features

Annals of Hematology, 2016
Thomas Burmeister, Jörg Westermann, Neuendorff Nina Rosa   +2 more
exaly  

Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Bcr-Abl-positive acute leukemia cells

Leukemia, 2001
M Porosnicu
exaly  

AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells

Cancer, 2005
Hagop Kantarjian, Ralph B Arlinghaus, Jorge Cortes   +2 more
exaly  

BCR/ABL Oncoprotein-Targeted Antitumor Activity of Antisense Oligodeoxynucleotides Complementary to BCR/ABL mRNA and Herbimycin A, an Antagonist of Protein Tyrosine Kinase: Inhibitory Effects on In Vitro Growth of Ph1-Positive Leukemia Cells and BCR/ABL Oncoprotein-Associated Transformed Cells

Leukemia and Lymphoma, 1993
Mihiro Okabe, Takuto Miyagishima, Masanobu Kobayashi   +2 more
exaly